RT Journal Article
SR Electronic
T1 Response to: ‘Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series’ by Narváez
JF Annals of the Rheumatic Diseases
JO Ann Rheum Dis
FD BMJ Publishing Group Ltd and European League Against Rheumatism
SP e124
OP e124
DO 10.1136/annrheumdis-2018-214477
VO 78
IS 11
A1 Khanna, Dinesh
A1 Jahreis, Angelika
A1 Lin, Celia J F
YR 2019
UL http://ard.bmj.com/content/78/11/e124.abstract
AB